The present disclosure is directed to methods of treatment, including treatment of a
myopathy by administering to a subject in need thereof an
elastase inhibitor in combination with a
glucocorticoid. The present disclosure is also directed to pharmaceutical compositions that include an
elastase inhibitor that can be used in such treatment.